study follow-up part in the outpatient area of the CRC. An important study milestone in this international multicenter study has now been achieved with the inclusion of the first German patient at the
legitimate interest of the MHH. My personal data will not be passed on to a third country or an international organization. After collection, my data will be stored in the Clinic of Pediatric Pneumology,
legitimate interest of the MHH. My personal data will not be passed on to a third country or an international organization. After collection, my data will be stored in the Clinic of Pediatric Pneumology,
legitimate interest of the MHH. My personal data will not be passed on to a third country or an international organization. After collection, my data will be stored in the Clinic of Pediatric Pneumology,
legitimate interest of the MHH. My personal data will not be passed on to a third country or an international organization. After collection, my data will be stored in the Clinic of Pediatric Pneumology,
legitimate interest of the MHH. My personal data will not be passed on to a third country or an international organization. After collection, my data will be stored in the Clinic of Pediatric Pneumology,
legitimate interest of the MHH. My personal data will not be passed on to a third country or an international organization. After collection, my data will be stored in the Clinic of Pediatric Pneumology,
legitimate interest of the MHH. My personal data will not be passed on to a third country or an international organization. After collection, my data will be stored in the Clinic of Pediatric Pneumology,
their tolerability and effects in CF, we often receive a feasibility request via the national and international networks of clinical trials and we then also participate in many of these clinical trials. This
legitimate interest of the MHH. My personal data will not be passed on to a third country or an international organization. After collection, my data will be stored in the Clinic of Pediatric Pneumology,